{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-023480","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2026-07-14T13:23:23+00:00","discovered_at":"2026-07-14T13:24:00.285464+00:00","generated_at":"2026-07-14T13:24:06.169630+00:00","sec_items":["3.03","5.03","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Genprex files 1:22 reverse stock split to address Nasdaq bid price deficiency; faces delisting risk","bullets":["Reverse stock split at 1:22 ratio effective July 16, 2026; shares outstanding to reduce from ~11.1M to ~505K.","Received Nasdaq delisting notice on June 10, 2026 for failing to maintain $1.00 bid price; requested hearing.","Acclaim-1 Phase 2a enrolling; Acclaim-3 Phase 2 expansion enrolling, interim analysis expected H1 2027.","Identified TROP-2 and PTEN as predictive biomarkers for REQORSA; plan to evaluate high TROP-2 expression.","No guarantee reverse split will regain compliance; risk of delisting and adverse impact on stock price and capital access."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-023480","json":"https://secwatch.observer/filing/0001437749-26-023480.json","markdown":"https://secwatch.observer/filing/0001437749-26-023480.md","text":"https://secwatch.observer/filing/0001437749-26-023480.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926023480/0001437749-26-023480-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774926023480/gnpx20260630_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-14T13:24:06.169630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}